Aurobindo Pharma USA, Inc.

Cases where party is a Patent Asserter

Only "example" cases are shown here, for full list contact Shawn Miller

Cases where party is an Alleged Infringer

Displaying 1 - 29 of 29
# Title Civil Action Venue Filing Date Asserter Categories Patent Asserter Alleged Infringer
1 Vertex Pharmaceuticals Incorporated v. Aurobindo Pharma Limited et al 1:23-cv-00582 D.Del.
Vertex Pharmaceuticals Incorporated
2 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
Theravance Biopharma US, Inc.
3 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
Theravance Biopharma R&D IP, LLC
4 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
Theravance Biopharma Ireland Limited
5 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
Mylan Specialty, L.P.
6 THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALTIES LTD. et al 1:23-cv-00926 D.N.J.
Mylan Ireland LTD.
7 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Cephalon, Inc.
8 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Eagle Pharmaceuticals, Inc.
9 Teva Pharmaceuticals International GmbH et al v. Aurobindo Pharma, Ltd. et al 1:20-cv-00632 D.Del.
  • 8 Product company
Teva Pharmaceuticals International GmbH
10 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Pharmaceutica
11 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Cilag GMBH (International)
12 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Pharmaceuticals Inc.
13 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Janssen Research & Development LLC
14 MITSUBISHI TANABE PHARMA CORPORATION et al v. AUROBINDO PHARMA USA, INC. 1:20-cv-03102 D.N.J.
  • 8 Product company
Mitsubishi Tanabe Pharma Corp.
15 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
Ares Trading SA
16 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
Merck KGaA
17 Merck KGaA et al v. Hopewell Pharma Ventures, Inc., et al. 1:22-cv-01365 D.Del.
Merck Serono SA
18 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
Merck Serono SA
19 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
Merck KGaA
20 Merck KGaA et al v. Aurobindo Pharma USA, Inc. et al 1:23-cv-00039 D.Del.
Ares Trading SA
21 Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al 1:22-cv-00971 D.Del.
  • 8 Product company
Covis Pharma GmbH
22 Covis Pharma GmbH et al v. Eugia Pharma Specialties Ltd. et al 1:22-cv-00971 D.Del.
  • 8 Product company
AMAG Pharmaceuticals, Inc.
23 BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al 3:22-cv-02345 D.N.J.
  • 8 Product company
Merck & Cie
24 BIOMARIN PHARMACEUTICAL INC. et al v. AUROBINDO PHARMACEUTICALS LTD. et al 3:22-cv-02345 D.N.J.
  • 8 Product company
BioMarin Pharmaceutical Inc.
25 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Sunovion Pharmaceuticals Inc.
26 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Bial - Portela & CA S.A.
27 Bial - Portela & CA S.A. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01270 D.Del.
  • 8 Product company
Bial - Holding, S.A.
28 Alcon Inc. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01391 D.Del.
  • 8 Product company
Alcon Laboratories, Inc.
29 Alcon Inc. et al v. Aurobindo Pharma Ltd. et al 1:22-cv-01391 D.Del.
  • 8 Product company
Alcon Inc.